5-hydroxytryptamine-3 receptor antagonist with or without short-course dexamethasone in the prophylaxis of radiation induced emesis: a placebo-controlled randomized trial of the National Cancer Institute of Canada Clinical Trials Group (SC19). [electronic resource]
Producer: 20060809Description: 3458-64 p. digitalISSN:- 1527-7755
- Antiemetics -- administration & dosage
- Canada
- Dexamethasone -- administration & dosage
- Drug Therapy, Combination
- Female
- Humans
- Male
- Middle Aged
- Nausea -- drug therapy
- Ondansetron -- administration & dosage
- Quality of Life
- Radiotherapy -- adverse effects
- Serotonin 5-HT3 Receptor Antagonists
- Serotonin Antagonists -- administration & dosage
- Treatment Outcome
- Vomiting -- etiology
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.